Events

Heidi Hagen and Dr. Howard Grimes Named Strategic Advisors   SOUTH SAN FRANCISCO, May 21, 2019 /PRNewswire/ -- NAVAN, Inc. (NAVAN), a privately-held biotechnology company enabling the development of next generation cell and gene therapies through its novel, non-viral NanoStraw platform, announced today the appointment Heidi Hagen, Co-founder and Chief Strategy...

Investors include Amgen Ventures, HTGF and Hemi Ventures   SOUTH SAN FRANCISCO, Calif., April 25, 2019 - NAVAN Technologies, Inc. (NAVAN), a privately-held biotechnology company enabling the development of next generation cell and gene therapies through its novel, non-viral NanoStraw platform, announced it had closed a seed...